Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05083741 · ClinicalTrials.gov registry record
Comparison of Chitodex Gel Vs NexFoam on Post-operative Outcomes in the Treatment of Chronic Rhinosinusitis
A clinical trial, sponsored by St. Louis University.
- Terminated
- Registry status
- 7
- Enrollment target
NCT05083741: Clinical Trial study, sponsored by St. Louis University.
NCT05083741 is a clinical trial that was terminated before completion, run by St. Louis University. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05083741 was terminated before completion, sponsored by St. Louis University.
- TERMINATED
- Registry status
- 7 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the efficacy and outcomes of Chitodex gel plus Kenalog versus Nexfoam plus Kenalog in patients with chronic rhinosinusitis (CRS) undergoing sinus surgery. Both dressings are already known to be beneficial in controlling postoperative bleeding and promote wound healing.
Primary Outcome
Outcome measured based on the wound healing in the sinus openings made during surgery.
Interventions
- DEVICE Chitogel
- DEVICE Nexfoam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2021-12-27 |
| Est. Completion | 2024-08-08 |
Why NCT05083741 stopped before completion
NCT05083741 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 7 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Chitogel is the first listed.
NCT05083741 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05083741 about?
NCT05083741 is a clinical study titled "Comparison of Chitodex Gel Vs NexFoam on Post-operative Outcomes in the Treatment of Chronic Rhinosinusitis". The purpose of this study is to compare the efficacy and outcomes of Chitodex gel plus Kenalog versus Nexfoam plus Kenalog in patients with chronic rhinosinusitis (CRS) undergoing sinus surgery. Both dressings are already known to be beneficial in controlling postoperative bleeding and promote wound...
What is the current status of trial NCT05083741?
This trial is currently terminated. The enrollment target is 7 participants. The study started on 2021-12-27. Estimated completion is 2024-08-08.
What interventions are being tested in trial NCT05083741?
The interventions under investigation include: Chitogel (DEVICE), Nexfoam (DEVICE).
Who is sponsoring clinical trial NCT05083741?
This trial is sponsored by St. Louis University, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI